Difference between revisions of "Insertion of ventricular assist device"

From WikiAnesthesia
(Created VAD)
 
Line 1: Line 1:
{{Infobox surgical procedure
{{Infobox surgical procedure
| anesthesia_type =  
| anesthesia_type = GA
| airway =  
| airway = ETT
| lines_access =  
| lines_access = Large bore IV, central access, arterial line
| monitors =  
| monitors = Standard ASA, arterial line monitor, CVP, TEE
| considerations_preoperative =  
| considerations_preoperative =  
| considerations_intraoperative =  
| considerations_intraoperative = Typically critically low EF requiring titrated induction
| considerations_postoperative =  
| considerations_postoperative =  
}}
}}
Line 36: Line 36:
|-
|-
|Cardiovascular
|Cardiovascular
|
|Critically low EF (15-20%) is not atypical. May also have underlying CAD, pulmonary HTN, and Grade 3 RHF
|-
|-
|Pulmonary
|Pulmonary
Line 58: Line 58:


=== Labs and studies<!-- Describe any important labs or studies. Include reasoning to justify the study and/or interpretation of results in the context of this procedure. If none, this section may be removed. --> ===
=== Labs and studies<!-- Describe any important labs or studies. Include reasoning to justify the study and/or interpretation of results in the context of this procedure. If none, this section may be removed. --> ===
Review cardiac studies including TTE, cardiac catheterization, etc.


=== Operating room setup<!-- Describe any unique aspects of operating room preparation. Avoid excessively granular information. Use drug classes instead of specific drugs when appropriate. If none, this section may be removed. --> ===
=== Operating room setup<!-- Describe any unique aspects of operating room preparation. Avoid excessively granular information. Use drug classes instead of specific drugs when appropriate. If none, this section may be removed. --> ===
Prepare infusions of norepinephrine and epinephrine. Also can consider infusions for insulin, dexmedetomidine, ketamine, cefazolin.


=== Patient preparation and premedication<!-- Describe any unique considerations for patient preparation and premedication. If none, this section may be removed. --> ===
=== Patient preparation and premedication<!-- Describe any unique considerations for patient preparation and premedication. If none, this section may be removed. --> ===
Line 70: Line 72:


=== Induction and airway management<!-- Describe the important considerations and general approach to the induction of anesthesia and how the airway is typically managed for this case. --> ===
=== Induction and airway management<!-- Describe the important considerations and general approach to the induction of anesthesia and how the airway is typically managed for this case. --> ===
Pre-induction arterial line typically indicated. Very careful titrated induction due to critically low EF.


=== Positioning<!-- Describe any unique positioning considerations, including potential intraoperative position changes. If none, this section may be removed. --> ===
=== Positioning<!-- Describe any unique positioning considerations, including potential intraoperative position changes. If none, this section may be removed. --> ===

Revision as of 11:54, 18 August 2022

Insertion of ventricular assist device
Anesthesia type

GA

Airway

ETT

Lines and access

Large bore IV, central access, arterial line

Monitors

Standard ASA, arterial line monitor, CVP, TEE

Primary anesthetic considerations
Preoperative
Intraoperative

Typically critically low EF requiring titrated induction

Postoperative
Article quality
Editor rating
In development
User likes
0

A ventricular assist device (VAD) is a pump designed to assist the left or right ventricle in severe heart failure. These devices may help the left ventricle (LVAD), the right ventricle (RVAD), or bilateral ventricles (BiVAD). The device may be placed as a permanent solution or as a bridge to cardiac transplant.

Overview

Indications

Severe heart failure

Surgical procedure

LVAD

Surgeons will perform sternotomy for exposure and either cardiopulmonary bypass (CPB) or extracorporeal membrane oxygenation (ECMO). The device is placed at the apex of the left ventricle with an outflow graft anastomosed to the ascending aorta.

Preoperative management

Patient evaluation

System Considerations
Airway
Neurologic
Cardiovascular Critically low EF (15-20%) is not atypical. May also have underlying CAD, pulmonary HTN, and Grade 3 RHF
Pulmonary
Gastrointestinal
Hematologic
Renal
Endocrine
Other

Labs and studies

Review cardiac studies including TTE, cardiac catheterization, etc.

Operating room setup

Prepare infusions of norepinephrine and epinephrine. Also can consider infusions for insulin, dexmedetomidine, ketamine, cefazolin.

Patient preparation and premedication

Regional and neuraxial techniques

Intraoperative management

Monitoring and access

Induction and airway management

Pre-induction arterial line typically indicated. Very careful titrated induction due to critically low EF.

Positioning

Maintenance and surgical considerations

Emergence

Postoperative management

Disposition

Pain management

Potential complications

Procedure variants

Variant 1 Variant 2
Unique considerations
Position
Surgical time
EBL
Postoperative disposition
Pain management
Potential complications

References